Atlas Trials

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

Clinical trial NCT00035594 · COMPLETED

Trial details

NCT number
NCT00035594
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Neutropenia
Start date
2002-02-01
Primary completion
2004-02-01
Enrollment
928

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.